Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6796446 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL28304211 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL2076631 | 0.77 | — | — | |
| SCHEMBL12714297 | 0.77 | — | — | |
| SCHEMBL10953310 | 0.72 | — | — | |
| SCHEMBL10964050 | 0.72 | — | — | |
| SCHEMBL28819302 | 0.69 | ACHE (0.30) | — | |
| SCHEMBL27984544 | 0.69 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL27766577 | 0.69 | — | — | |
| SCHEMBL22115649 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109912454-A | The synthetic method of 3- ethoxy propylene nitrile and 3,3- diethoxy propionitrile mixture | 南京欧信医药技术有限公司 | 2019-06-21 | — | — | CN | claimed |
| CN-105399646-B | A kind of cytosine intermediate 3, the preparation method of 3- diethoxy propionitrile | 新乡学院 | 2018-08-24 | — | — | CN | claimed |
| CN-105399646-A | Preparation method of cytosine intermediate 3,3-diethoxypropionitrile | UNIV XINXIANG | 2016-03-16 | — | — | CN | claimed |
| CN-102633680-B | Catalyst for preparing 3,3-diethoxyl propionitrile and preparation method of catalyst | UNIV LANGZHOU | 2014-06-11 | — | — | CN | claimed |
| CN-102295578-B | Synthetic method of 3,3-diethoxypropionitrile | GANSU RES INST OF CHEMICAL INDUSTRY | 2014-04-02 | — | — | CN | claimed |
| CN-102816123-A | Preparation method for cytosine | SHANGYU HUAKE CHEMICAL CO LTD | 2012-12-12 | — | — | CN | claimed |
| CN-102633680-A | Catalyst for preparing 3,3-diethoxyl propionitrile and preparation method of catalyst | UNIV LANGZHOU | 2012-08-15 | — | — | CN | claimed |
| CN-102295578-A | Synthetic method of 3,3-diethoxypropionitrile | — | 2011-12-28 | — | — | CN | claimed |
| US-12215100-B2 | Anticancer compounds | PHARMA MAR, S.A. (ES) | 2025-02-04 | — | — | US | disclosed |
| EP-4017844-B1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2024-01-24 | — | — | EP | disclosed |
| EP-3898613-B1 | ANTICANCER COMPOUNDS | PHARMA MAR SA (ES) | 2023-08-09 | — | — | EP | disclosed |
| US-20220306587-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2022-09-29 | — | — | US | disclosed |
| EP-4017844-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BioScience SA (CH) | 2022-06-29 | — | — | EP | disclosed |
| CN-114555567-A | Compounds and their use for the treatment of infectious diseases and cancer | AC生命科学有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-7030112-B2 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-18 | — | — | US | disclosed |
| CN-1243027-C | Polymerization process | KANEGAFUCHI CHEMICAL IND (JP) | 2006-02-22 | — | — | CN | disclosed |
| WO-2005030144-A2 | PYRROLOPYRIDAZINE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20040209886-A1 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-21 | — | — | US | disclosed |
| CN-1314813-A | Novel isoxazolinone antibacterial agent | BRISTOL MYERS SQUIBB CO (US) | 2001-09-26 | — | — | CN | disclosed |
| CN-1303396-A | Polymerization method | KANEGAFUCHI CHEMICAL IND (JP) | 2001-07-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209886-A1 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | PCNA, DPYD, MALT1 | ALDH1A1 544/4885TSHR 3274/4885 |
| US-20220306587-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | SGPL1, SPHK1, S1PR1 | ALDH1A1 381/4885TSHR 2940/4885 |
| US-12215100-B2 | Anticancer compounds | TP53, MCL1, MYC | ALDH1A1 795/4885TSHR 4635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.